In mounting woes for Monsanto, Competition Commission has ordered another detailed probe against the genetically-modified seed major for alleged unfair business practices.
This is the third time this year that CCI is ordering a probe against the company and the latest one is based on a complaint filed by Hyderabad-based Amar Biotech pertaining to Sub-Licensing Agreement (SLA).
The latest complaint was filed against Mahyco Monsanto Biotech (India) Ltd, Monsanto Holdings Pvt Ltd, Monsanto Company and Maharashtra Hybrid Seeds Company Ltd.
Ordering the probe, Competition Commission of India (CCI) said that in the present case, “the SLA was not extended/ renewed by Opposite Party 1 (Mahyco Monsanto Biotech) after efflux of time”.
Full Content: Financial Express
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DirecTV and Disney Resolve Dispute, Restore Programming for Subscribers
Sep 15, 2024 by
CPI
UK Antitrust Authority Raises Concerns Over Vodafone-Three Merger
Sep 15, 2024 by
CPI
Brazilian Supreme Court Lifts Freeze on Starlink Accounts, Transfers $3.3 Million to National Treasury
Sep 15, 2024 by
CPI
Steptoe Expands Antitrust Practice with Key London Hire
Sep 15, 2024 by
CPI
Instant Ad Auctions at the Heart of Google’s Federal Monopoly Case
Sep 15, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Canada & Mexico
Sep 3, 2024 by
CPI
Competitive Convergence: Mexico’s 30-Year Quest for Antitrust Parity with its Northern Neighbor
Sep 3, 2024 by
Francisco Javier Núñez Melgoza
Competition and Digital Markets in North America: A Comparative Study of Antitrust Investigations in Mexico and the United States
Sep 3, 2024 by
Julio Garcia
Recent Antitrust Development in Mexico: COFECE’s Preliminary Report on Amazon and Mercado Libre
Sep 3, 2024 by
Alejandra Palacios Prieto
The Cost of Making COFECE Disappear
Sep 3, 2024 by
Mateo Fernández